Iovance Biotherapeutics Inc. logo

Iovance Biotherapeutics Inc.

IOVA | NASDAQ
Chart Builder DCF Calculator
$10.19
-$0.06 (-0.59%)
At close: Sep 21, 2026, 4:00 PM ET
$10.17
-$0.02 (-0.20%)
Pre-market: Sep 22, 2026, 9:02 AM ET
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
-390.98M -372.18M -444.04M -395.89M -342.25M -259.58M
Depreciation & Amortization
34.46M 43.61M 33.13M 21.14M 13.98M 1.14M
Stock-Based Compensation
61.58M 109.63M 62.63M 84.02M 69.77M 40.89M
Other Working Capital
9.71M -5.61M -1.08M -8.78M 17.58M 5.95M
Other Non-Cash Items
18.87M -8.65M -3.54M 871K 6.01M 7.57M
Deferred Income Tax
-2.07M -2.83M -3.48M n/a n/a 1.87M
Change in Working Capital
-24.27M -122.56M -6.52M -2.89M 24.55M 2.98M
Operating Cash Flow
-302.41M -352.98M -361.82M -292.76M -227.94M -205.13M
Capital Expenditures
-33.84M -11.07M -22.29M -20.43M -37.57M -46.79M
Cash Acquisitions
n/a -52.57M -212.63M -276.88M -37.71M 271.06M
Purchase of Investments
-318.67M -460.77M -205.9M -245.82M -725.21M -947.66M
Sales Maturities Of Investments
400M 428M 285.58M 522.7M 762.91M 676.6M
Other Investing Acitivies
n/a n/a n/a 276.88M 37.71M -271.06M
Investing Cash Flow
47.5M -96.41M -155.24M 256.46M 132K -317.85M
Debt Repayment
n/a n/a n/a n/a 1M n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-7.06M -6.64M -322K 648K 35.11M 9.38M
Financial Cash Flow
300.77M 390.66M 462.96M 190.15M 239.27M 576.42M
Net Cash Flow
47.38M -59.27M -56.84M 153.85M 11.46M 53.44M
Free Cash Flow
-336.24M -364.05M -384.11M -313.18M -265.52M -251.93M
Adj. Free Cash Flow
-397.82M -473.67M -446.74M -397.2M -335.28M -292.81M
Maintenance CapEx
n/a n/a n/a -20.43M -13.98M -1.14M
Growth CapEx
-33.84M -11.07M -22.29M n/a -23.59M -45.65M
Owner Earnings
-302.41M -352.98M -361.82M -313.18M -241.92M -206.27M

© 2026 bestshares.com. All rights reserved.